ARBOVAX
Arbovax will focus on the research and development of a unique and proprietary technology that can be used to make vaccines to target unmet clinical needs in markets that have traditionally been neglected by major vaccine producers. Arbovax intends to engage in the preclinical and clinical development of vaccine products for the prophylactic treatment of arthropod-borne diseases that collectively infect over 100 million people annually and put over 2.5 billion people at risk of infection. The b... usiness strategy of the Company is to develop the technology to a point where it can be licensed to commercial partners for manufacture and distribution. Arbovax’s patent-protected technology is based upon multiple deletions in the transmembrane portion of the virus allowing it to replicate in insect cells, but not in mammalian cells. This forms the basis for the creation of a family of vaccines that offer the following advantages:
ARBOVAX
Social Links:
Industry:
Biotechnology Health Care Manufacturing Medical
Founded:
2005-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.arbovaxinc.com
Total Employee:
1+
Status:
Active
Total Funding:
3.43 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Amazon SSL By Default Mobile Non Scaleable Content GoDaddy DNS AWS Global Accelerator OpenResty GoDaddy SSL
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Nerium Biotechnology
Nerium Biotechnology engages in the development of oleander-based products for the treatment of proliferative diseases and viral infections.
NxStage Medical
NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney
Premier Nutrition
Premier Nutrition, Inc. engages in the research, development, and production of nutrition products. It offers nutrition bars, protein
Renovar
Renovar is engaged in the development of diagnostic tests for the treatment of kidney diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
SRS Medical Systems
SRS Medical is a manufacturer of devices for the diagnosis of voiding disorders and the conservative treatments of urinary incontinence.
Current Employees Featured
Founder
More informations about "Arbovax"
Arbovax - Crunchbase Company Profile & Funding
Arbovax engages in the preclinical and clinical development of vaccine products for the prophylactic treatment of arthropod-borne diseases.See details»
Arbovax Inc - Company Profile & Staff Directory | ContactOut
ARBOVAXâ„¢, Inc. has a unique technology that modifies arthropod-borne viruses (arboviruses) making them unable to replicate in mammalian cells. Arbovax will leverage this technology …See details»
Arbovax Inc - LinkedIn
ARBOVAXâ„¢, Inc. has a unique technology that modifies arthropod-borne viruses (arboviruses) making them unable to replicate in mammalian cells. Arbovax will leverage this technology through ...See details»
Arbovax Company Profile | Management and Employees List
Arbovax Profile and History Arbovax is engaged in preclinical development of vaccines for protection against mosquito-borne diseases that collectively infect over 100 million people …See details»
Arbovax - Overview, News & Similar companies | ZoomInfo.com
View Arbovax (www.arbovax.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Arbovax Inc - Company Profile and News - Bloomberg Markets
Company profile page for Arbovax Inc including stock price, company news, executives, board members, and contact informationSee details»
Arbovax Inc Overview | SignalHire Company Profile
Arbovax will leverage this technology through partnership... Show more Organization Website arbovaxinc.com Arbovax Inc industries Biotech Headquarters Location 617 Hutton St, Raleigh, …See details»
ARBOVAX, INC. Company Profile | Raleigh, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ARBOVAX, INC. of Raleigh, NC. Get the latest business insights from Dun & Bradstreet.See details»
Arbovax Inc. - scrip.citeline.com
In Vivo briefly summarizes the technologies of these recently founded companies: Angiologix, Arbovax, MicuRx Pharmaceuticals, OrphageniX, PregLem and Zora Biosciences.See details»
Malcolm Thomas - CEO - Arbovax Inc | LinkedIn
Aug 15, 2012 CEO at Arbovax Inc · Experience: Arbovax Inc · Location: Raleigh · 237 connections on LinkedIn. View Malcolm Thomas’ profile on LinkedIn, a professional …See details»
Arbovax, Inc. Asset Profile | Preqin
Arbovax, Inc. is based in the US and engages in the research and development of vaccines against arthropod-borne diseases.See details»
One-Shot Dengue Fever Vaccine Moves Closer to Reality - pr.com
Arbovax, Inc. is an early stage biotechnology company based in Raleigh NC, developing a novel and innovative technology to facilitate the development of vaccines against insect-borne viruses.See details»
New Virus Modification Approach to Creating Vaccines for Insect …
Jul 7, 2011 About the company: Arbovax, Inc. is an early stage biotechnology company based in Raleigh NC, developing a novel and innovative technology to facilitate the development of …See details»
Arbovax Completes Successful Pre-Clinical Trial of Tetravalent …
Arbovax’s initial focus is dengue fever because it is ranked second only to malaria by the World Health Organization for its devastating global impact with 2.5 to 3 billion people, more than 40 ...See details»
Arbovax’s Dengue vaccine is now ready for clinical trials - NC State …
Mar 20, 2013 Arbovax’s Dengue vaccine is now ready for clinical trials, WRAL Tech Wire, March 19, 2013. Vaccine developer Arbovax, a spinout from NC State University, is now ready to test …See details»
New vaccine could offer long-term protection from mosquito …
Jul 25, 2014 Clinical stage biotechnology company, Arbovax Inc., created a vaccine for Chikungunya, the company announced last month.See details»
Arbovax - Products, Competitors, Financials, Employees, …
Arbovax has a unique technology that modifies arthropod-borne viruses (arboviruses) making them unable to replicate in mammalian cells. Arbovax will leverage this technology through …See details»
Arbovax Closing in on Vaccine for Chikungunya - PR.com
Arbovax, Inc., a clinical stage biotechnology company, has successfully demonstrated in an animal model the efficacy of its vaccine technology for the...See details»
Arbovax - Company Profile - Tracxn
Arbovax - Vaccines against insect-borne viral diseases. Raised a total funding of $3.43M over 2 rounds from 1 investor.See details»
Scams Details - Better Business Bureau
Jun 8, 2024 This content is based on victim and potential victim accounts. Government agencies and legitimate business names and phone numbers are often used by scam artists to take …See details»